TMC The Metals Company Is Poised to Surge: 2 Catalysts That Could Drive Gains Over the Next Year

TMC The Metals Company remains a highly speculative $2.2 billion, pre-revenue, money-losing miner whose stock is down 47% since its 2020 IPO and 24% over the past year. The positive catalysts are NOAA approval to probe a 122,000-square-kilometer Pacific region for critical minerals and the possibility of further U.S. government support to loosen China's grip on rare-earth and critical mineral supply chains. The article frames these as potential rally triggers, but execution risk remains high and the news is more commentary than immediate market-moving information.

Analysis

This is less a clean fundamentals story than an event-driven squeeze on a deeply optionality-driven balance sheet. The market is likely underappreciating how little it takes to re-rate a pre-revenue critical-minerals name: one incremental permitting win, one partner commitment, or one credible path to first extraction could force a violent reassessment because the equity is effectively a long-duration call option on regulatory permission and execution. The flip side is that absent a financing bridge, every delay increases dilution risk and pushes more of the enterprise value into the jurisdictional/regulatory bucket rather than the resource bucket.

The biggest second-order beneficiary is not necessarily the company itself but adjacent critical-minerals and defense-adjacent supply-chain names that gain if policymakers keep leaning into non-China sourcing. If Washington keeps signaling support, the market may start to price a wider set of permitting winners and service providers, while legacy battery and metals supply chains could face a modest multiple headwind from increased long-term substitution pressure. Over a 3-12 month horizon, the key question is whether policy support converts from rhetorical tailwind into operational de-risking; if not, the trade remains a momentum burst rather than a durable rerating.

The main bearish catalyst is time: each quarter without commercial-scale progress raises the probability that investors treat this as a perpetual-funding story rather than a near-term asset. Any denial, procedural delay, or negative environmental/legal headline would likely compress the stock fast because the valuation has little hard-asset cushion. The consensus may be missing that the real catalyst is not permission alone but proof of repeatability; the stock can pop on approvals, but it likely needs evidence of scalable execution to sustain a move.

Key Decisions for Investors

• Speculative long only as an event trade: build a small position in TMCWW/TMC into weakness, sized at <=50 bps NAV, with a 1-3 month horizon and a hard stop on any regulatory setback; target a 2-3x payoff if another approval or partnership catalyst lands.
• Use options rather than equity where possible: buy near-dated calls 60-120 days out on TMC into pullbacks to capture binary upside while capping dilution and policy risk; take profits on a 50-75% move because post-news decay can be severe.
• Pair trade: long a diversified critical-minerals beneficiary basket versus short a high-beta, pre-revenue resource name with no visible permitting progress over the next 6-12 months; the thesis is that policy tailwinds will be rewarded only where execution is de-risked.
• Avoid chasing after approval headlines; enter only after volatility compresses or on a failed breakout, since the stock’s gap-risk is large and the reward-to-risk deteriorates sharply once momentum is fully priced.
• Monitor for financing or JV announcements over the next 1-2 quarters; if a credible strategic partner appears, that is the signal to add, because it converts a pure regulatory option into a funded development story.